Literature DB >> 32640277

Cyclooxygenases and the cardiovascular system.

Jane A Mitchell1, Nicholas S Kirkby2, Blerina Ahmetaj-Shala3, Paul C Armstrong4, Marilena Crescente4, Plinio Ferreira5, Maria Elisa Lopes Pires5, Ricky Vaja5, Timothy D Warner4.   

Abstract

Cyclooxygenase (COX)-1 and COX-2 are centrally important enzymes within the cardiovascular system with a range of diverse, sometimes opposing, functions. Through the production of thromboxane, COX in platelets is a pro-thrombotic enzyme. By contrast, through the production of prostacyclin, COX in endothelial cells is antithrombotic and in the kidney regulates renal function and blood pressure. Drug inhibition of COX within the cardiovascular system is important for both therapeutic intervention with low dose aspirin and for the manifestation of side effects caused by nonsteroidal anti-inflammatory drugs. This review focuses on the role that COX enzymes and drugs that act on COX pathways have within the cardiovascular system and provides an in-depth resource covering COX biology and pharmacology. The review goes on to consider the role of COX in both discrete cardiovascular locations and in associated organs that contribute to cardiovascular health. We discuss the importance of, and strategies to manipulate the thromboxane: prostacyclin balance. Finally within this review the authors discuss testable COX-2-hypotheses intended to stimulate debate and facilitate future research and therapeutic opportunities within the field.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aspirin; Celecoxib; Cyclooxygenase; Fish oil; Heart attack; Ibuprofen

Year:  2020        PMID: 32640277     DOI: 10.1016/j.pharmthera.2020.107624

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  7 in total

1.  Prenatal Activation of Glucocorticoid Receptors Induces Memory Impairment in a Sex-Dependent Manner: Role of Cyclooxygenase-2.

Authors:  Mai Abul; Maie Dawoud Al-Bader; Abdeslam Mouihate
Journal:  Mol Neurobiol       Date:  2022-04-09       Impact factor: 5.590

2.  Fimbristylis aestivalis Vahl: a potential source of cyclooxygenase-2 (COX-2) inhibitors.

Authors:  Saduddin Talukder; Khondoker Shahin Ahmed; Hemayet Hossain; Tarek Hasan; Israt Jahan Liya; Muhammed Amanat; Nurun Nahar; Md Sadikur Rahman Shuvo; A F M Shahid Ud Daula
Journal:  Inflammopharmacology       Date:  2022-09-03       Impact factor: 5.093

3.  A fluorescent target-guided Paal-Knorr reaction.

Authors:  Sachin B Wagh; Vladimir Maslivetc; James J La Clair; Alexander Kornienko
Journal:  RSC Adv       Date:  2020-10-07       Impact factor: 4.036

Review 4.  New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases.

Authors:  Wujun Chen; Yingjie Zhong; Nuan Feng; Zhu Guo; Shuai Wang; Dongming Xing
Journal:  Mol Med       Date:  2021-09-30       Impact factor: 6.354

5.  An Investigation into the Interaction between Double Hydroxide-Based Antioxidant Benzophenone Derivatives and Cyclooxygenase 2.

Authors:  Yanan Qiao; Yuxi Qin; Lihua Liu; Xi Chen; Yunlan Li; Qingshan Li
Journal:  Molecules       Date:  2021-11-01       Impact factor: 4.411

6.  Recent findings on the cellular and molecular mechanisms of action of novel food-derived antihypertensive peptides.

Authors:  Innocent U Okagu; Timothy P C Ezeorba; Emmanuel C Aham; Rita N Aguchem; Regina N Nechi
Journal:  Food Chem (Oxf)       Date:  2022-01-25

Review 7.  Prostanoid Metabolites as Biomarkers in Human Disease.

Authors:  Helena Idborg; Sven-Christian Pawelzik
Journal:  Metabolites       Date:  2022-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.